Dr. Bucshon, Rep. Carter, and Rep. Harshbarger Introduce Legislation to Ensure Access and Transparency in 340B Drug Pricing Program
Congressman Larry Bucshon
by
1w ago
WASHINGTON – Today, U.S. Representatives Larry Bucshon, MD (R-IN-08), Buddy Carter (R-GA-01), and Diana Harshbarger (R-TN-01) introduced the 340B Affording Care for Communities and Ensuring a Strong Safety-Net Act (340B ACCESS Act). This legislation establishes critical oversight and transparency of the 340B program - while providing clear, practical, and achievable solutions to ensure the 340B pr ..read more
Visit website
Dr. Bucshon’s Statement on House Passage of the Promoting Resilient Supply Chains Act
Congressman Larry Bucshon
by
3w ago
WASHINGTON – U.S. Representative Larry Bucshon, M.D. (R-IN-08), a senior member of the House Energy and Commerce Committee, issued the following statement after the House of Representatives passed the Promoting Resilient Supply Chains Act (H.R. 6571). Dr. Bucshon introduced H.R. 6571 with U.S. Representative Lisa Blunt Rochester (D-DE-At Large), which will help ensure the United States can better ..read more
Visit website
Dr. Bucshon’s Statement on House Passage of Deploying American Blockchains Act
Congressman Larry Bucshon
by
3w ago
WASHINGTON – U.S. Representative Larry Bucshon, M.D. (R-IN-08), a senior member of the House Energy and Commerce Committee, issued the following statement after the House of Representatives passed the Promoting Resilient Supply Chains Act (H.R. 6571). Dr. Bucshon introduced H.R. 6571 with U.S. Representative Lisa Blunt Rochester (D-DE-At Large), which will help ensure the United States can better ..read more
Visit website
Drs. Bucshon & Ruiz Introduce Clinical Trial Modernization Act
Congressman Larry Bucshon
by
3w ago
WASHINGTON – On Wednesday, Congressman Larry Bucshon, M.D. (R-IN-08) and Congressman Raul Ruiz, M.D. (D-CA-25) introduced bipartisan legislation (H.R. 8412) to improve participation in clinical trials by underrepresented populations. The Clinical Trial Modernization Act builds on the successes of clinical trials legislation passed into law last Congress by addressing economic barriers that can pre ..read more
Visit website
Dr. Bucshon’s Statement on House Passage of ADVANCE Act
Congressman Larry Bucshon
by
1M ago
WASHINGTON – U.S. Representative Larry Bucshon, M.D. (R-IN-08), a senior member of the House Energy and Commerce Committee, issued the following statement after the House of Representatives passed on Wednesday, May 8, 2024, the Accelerating Deployment of Versatile, Advanced Nuclear for Clean Energy (ADVANCE) Act, which will help expand the use of nuclear energy, as part of S. 870. Rep. Bucshon’s A ..read more
Visit website
Dr. Bucshon’s Statement on Passage of National Security Supplemental Appropriations
Congressman Larry Bucshon
by
1M ago
WASHINGTON – U.S. Representative Larry Bucshon, M.D. (R-IN-08) issued the following statement after the House of Representatives passed a national security supplemental appropriations package, which will provide resources to Israel, Ukraine, the Indo-Pacific, and address other national security matters: “I came of age during the presidency of Ronald Reagan, and I believe as he did that the only re ..read more
Visit website
Dr. Bucshon Announces Winner of 2024 Eighth District Congressional Art Competition
Congressman Larry Bucshon
by
1M ago
EVANSVILLE – U.S. Representative Larry Bucshon, M.D. (R-IN-08) announced Jaylee Farrar, a student at Vincennes Lincoln High School, as the 2024 winner of the Eighth District Congressional Art Competition. This competition is part of a nationwide visual art competition to recognize the artistic endeavors of high school students. The winning piece of artwork was chosen out of the more than 80 submis ..read more
Visit website
Bucshon, DeGette Release Statement on Burdensome FDA Rule Regulating Lab-Developed Tests
Congressman Larry Bucshon
by
1M ago
WASHINGTON D.C. — Today, Congressman Larry Bucshon, M.D. (IN-08) and Congresswoman Diana DeGette (CO-01) released the following statement after the Food and Drug Administration (FDA) finalized a rule regulating lab-developed tests (LDTs), a subset of in-vitro clinical tests (IVCTs). “Rational oversight of in-vitro diagnostics, including laboratory-developed tests, is vital for innovation in diagno ..read more
Visit website
Dr. Bucshon’s Statement on Japanese Prime Minister Kishida’s Address to Congress
Congressman Larry Bucshon
by
1M ago
WASHINGTON – U.S. Representative Larry Bucshon, M.D. (R-IN-08), who is a Co-Chair of the Congressional Study Group on Japan and served as a House member on the official escort committee for the Prime Minister’s address, released the statement following Japanese Prime Minister Fumio Kishida’s address to a Joint Meeting of Congress: “The United States-Japan relationship is one of the most critical a ..read more
Visit website
Dr. Bucshon’s Statement on Return of Direct Air Service between Evansville and Chicago
Congressman Larry Bucshon
by
1M ago
WASHINGTON – U.S. Representative Larry Bucshon, M.D. (R-IN-08) issued the following statement after Evansville Regional Airport officials announced the resumption of American Airlines’ direct air service between Evansville Regional Airport (EVV) and Chicago’s O’Hare International Airport (ORD): “Today’s announcement regarding American Airlines’ decision to restore direct air service between Evansv ..read more
Visit website

Follow Congressman Larry Bucshon on FeedSpot

Continue with Google
Continue with Apple
OR